Potential for drug development from some species of the Litsea genus of the lauraceae family
Keywords:
Litsea, Litsea rubescens, traditional medicinal plants, drug development, essential oilAbstract
The development of new drugs derived from medicinal plants has become a research trend attracting significant interest from scientists worldwide, based on traditional knowledge of use, availability of raw materials, safety, and other advantages of herbal resources. The genus Litsea comprises more than 400 species distributed across tropical and subtropical regions of Asia as well as North and South America. Among them, 48 species have been used as medicinal plants in several countries, including China, India, Korea, Japan, and Vietnam, for the treatment of various conditions such as influenza, stomachache, diarrhea, diabetes, vomiting, bone pain, and certain diseases related to the central nervous system. Plants belonging to this genus contain more than 407 identified bioactive compounds with diverse structural classes, of which 137 compounds have so far been reported exclusively in Litsea. Many species of this genus are rich in alkaloid, lacton, flavonoid, terpenoid, lignan, essential oils, and several other phytochemicals. These constituents suggest a wide spectrum of biological activities, including anticancer, antiinflammatory, antimicrobial, antioxidant, antidiabetic, and insecticidal effects, as well as activity against HIV and promising potential for cardiovascular protection. These findings provide an important scientific basis for further in-depth studies, particularly on mechanisms of action and toxicity, to identify therapeutic effects that could support the development of new drugs.